Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04139902 |
| Title | PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor TSR-022 and PD-1 Inhibitor Dostarlimab (TSR-042) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Diwakar Davar |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Georgetown University Medical Center | RECRUITING | Washington | District of Columbia | 20007 | United States | Details |
| Massachusetts General Hospital | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
| Dana Farber Cancer Institute | NOT_YET_RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| UPMC Hillman Cancer Center | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| UPMC Hillman Cancer Center Washington | RECRUITING | Washington | Pennsylvania | 15301 | United States | Details |